- LINKS
-
About us
Click here for more information about this topic.
More information
-
- Printer friendly version
- Bookmark this page
- gross
Top 10 Products
Our ten top-selling products in 2010
The future of medicine lies in individual approaches and in building bridges between prevention, diagnosis and therapy. Bayer HealthCare Pharmaceuticals meets this challenge with proven, successful products based on many decades of knowledge and experience.
| Product | Indication | Sales |
|---|---|---|
| Betaferon®/Betaseron® | multiple sclerosis | € 1,206 million |
| YAZ®/ Yasmin®/ Yasminelle® |
hormonal contraceptive | € 1,111 million |
| Kogenate® | hemophilia | € 1,004 million |
| Nexavar® | kidney and liver cancer | € 705 million |
| Adalat® | high blood pressure | € 664 million |
| Mirena® | hormonal intrauterine delivery system for contraception | € 539 million |
| Avalox®/Avelox® | respiratory tract infections | € 497 million |
| Levitra® | drug for treating erectile dysfunction | € 429 million |
| Aspirin® Cardio | prevention heart attack | € 358 million |
| Glucobay® | Diabetes | € 347 million |
Products are ranked by full year 2010 sales.
- Age-related macular degeneration (AMD)
- Breast cancer
- Central retinal vein occlusion (CRVO)
- Colorectal Cancer (CRC)
- Contraception
- Deficiency Testosterone
- Diabetes
- Diabetic macular edema (DME)
- Endometriosis
- Erectile dysfunction
- Gastrointestinal stromal tumor (GIST)
- Gynecological therapy
- Heart attack
- Heartattack and stroke
- Hemophilia
- High blood pressure
- Infectious diseases
- Liver cancer
- Lung cancer
- Menopausal complaints
- Multiple sclerosis
- Peripheral arterial occlusive disease
- Premenstrual dysphoric disorder (PMDD)
- Prostate cancer
- Pulmonary arterial hypertension
- Renalcell carcinoma
- Stroke
- Thrombosis
- Thyroid Cancer
Page tools
- B/W version
- A | A | A | Font size
